Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands

Table 3 Daily cost of regimen components

Protease inhibitor	Daily costs (€)
tipranavir/ritonavir	28.00
Comparator protease inhibitor
lopinavir/ritonavir	14.54
amprenavir	15.21
Indinavir	8.93
Saquinavir	8.58
Background antiretroviral
Abacavir	9.54
Didanosine	6.96
Efavirenz	8.68
Emtricitabine	6.49
Enfuvirtide	25.27
Lamivudine	6.20
Nevirapine	7.79
Stavudine	5.38
Tenofovir	11.70
Zidovudine	8.04

Daily cost (Euro price level 2006) in the Netherlands of tipranavir, comparator protease inhibitors and antiretroviral background regimen components in the RESIST-2 trial (source: Z-index Nov. 2006) [20].

ISSN: 1478-7547